{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:43:01Z","timestamp":1790775781969,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003360","name":"Ligue Genevoise Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jhepr.2021.100231","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T01:12:28Z","timestamp":1611018748000},"page":"100231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["NAFLD and MAFLD as emerging causes of HCC: A populational study"],"prefix":"10.1016","volume":"3","author":[{"given":"Shuna","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Neyroud-Caspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Spahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Gkouvatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Giostra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Magini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Frossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Eve","family":"Bascaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Vernaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Zampaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100231_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Canc J Clin"},{"key":"10.1016\/j.jhepr.2021.100231_bib2","series-title":"SEER Cancer Statistics Review, 1975\u20132014","first-page":"1","author":"Howlader","year":"2017"},{"key":"10.1016\/j.jhepr.2021.100231_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1055-9965.EPI-19-1052","article-title":"Sex and race disparities in the incidence of hepatocellular carcinoma in the United States examined through age\u2013period\u2013cohort analysis","volume":"29","author":"Zhang","year":"2020","journal-title":"Canc Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jhepr.2021.100231_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global\u00a0epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100231_bib6","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100231_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100231_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00535-014-0973-8","article-title":"Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study","volume":"50","author":"Tateishi","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100231_bib12","author":"Forman","year":"2013"},{"key":"10.1016\/j.jhepr.2021.100231_bib13","series-title":"Classification Internationale des Maladies Pour l\u2019Oncologie","article-title":"International classification of diseases for Oncology","author":"Fritz","year":"2000"},{"key":"10.1016\/j.jhepr.2021.100231_bib14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert Panel on detection, evaluation, and treatment of high Blood Cholesterol in adults (adult treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2021.100231_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222136","article-title":"A\u00a0population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland","volume":"14","author":"Schaffar","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhepr.2021.100231_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2010.07.015","article-title":"Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate","volume":"54","author":"Myers","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib17","series-title":"Neuchatel: Office f\u00e9d\u00e9ral de la statistique","year":"2018"},{"key":"10.1016\/j.jhepr.2021.100231_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10620-015-3952-x","article-title":"Development and validation of an algorithm to identify nonalcoholic fatty liver disease in the electronic medical record","volume":"61","author":"Corey","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2021.100231_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001\u20132013","volume":"149","author":"Beste","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100231_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib21","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ijc.30211","article-title":"International trends in liver cancer incidence, overall and by histologic subtype, 1978\u20132007","volume":"139","author":"Petrick","year":"2016","journal-title":"Int J Canc"},{"key":"10.1016\/j.jhepr.2021.100231_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","article-title":"Global trends and predictions in hepatocellular carcinoma mortality","volume":"67","author":"Bertuccio","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apt.14261","article-title":"Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period","volume":"46","author":"Pais","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2021.100231_bib24","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20152","article-title":"Nonalcoholic fatty liver disease burden \u2013 Switzerland 2018\u20132030","volume":"149","author":"Goossens","year":"2019","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jhepr.2021.100231_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100231_bib26","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100231_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2468-1253(20)30340-X","article-title":"The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease","volume":"6","author":"Mendez-Sanchez","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2468-1253(20)30213-2","article-title":"Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib29","article-title":"The NAFLD-MAFLD debate: eminence vs evidence","author":"Fouad","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100231_bib30","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2020.06.016","article-title":"MAFLD criteria overlooks a number of patients with severe steatosis: is it clinically relevant?","volume":"73","author":"Huang","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib31","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","author":"Younossi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100231_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver Cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jhepr.2021.100231_bib33","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2021.100231_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.26338","article-title":"Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults","volume":"131","author":"Borena","year":"2012","journal-title":"Int J Canc"},{"key":"10.1016\/j.jhepr.2021.100231_bib35","first-page":"4222","article-title":"Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma","volume":"17","author":"Li","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jhepr.2021.100231_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/hep.31057","article-title":"Associations between prediagnostic concentrations of circulating sex steroid hormones and liver cancer among post-menopausal women","volume":"72","author":"Petrick","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100231_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1186\/s12885-019-6167-2","article-title":"Distinct molecular etiologies of male and female hepatocellular carcinoma","volume":"19","author":"Natri","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2021.100231_bib38","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.29971","article-title":"Population attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"122","author":"Makarova-Rusher","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2021.100231_bib39","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.29660","article-title":"Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: results from two prospective cohort studies","volume":"67","author":"Simon","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100231_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhepr.2021.100231_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100231_bib43","unstructured":"Obesity Update \u2013 Organisation for Economic Co-operation and Development (OECD); http:\/\/www.oecd.org\/health\/obesity-update.htm Accessed 22 May\u00a02020."},{"key":"10.1016\/j.jhepr.2021.100231_bib44","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","author":"Abarca-G\u00f3mez","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2021.100231_bib45","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","author":"Zhou","year":"2016","journal-title":"Lancet"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:26:35Z","timestamp":1762899995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2589555921000070"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100231","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAFLD and MAFLD as emerging causes of HCC: A populational study","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100231"}}